课题基金 / 基金详情

Role of Aging on cardiac macrophage dysfunction and heart failure during infection

Role of Aging on cardiac macrophage dysfunction and heart failure during infection
衰老对感染期间心脏巨噬细胞功能障碍和心力衰竭的作用
批准号:
10447405
负责人:
Murugesan Rajaram
金额:
$23.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-05-15 至 2024-02-29
关键词:
AgeAgingApoptoticArrhythmiaBiology of AgingCardiacCardiac MyocytesCardiac OutputCardiac developmentCardiac healthCardiovascular DiseasesCardiovascular systemCell AgingCellsCessation of lifeChoristomaChromatinChronicCollagenComplicationDataData SetDementiaDevelopmentDiabetes MellitusDiseaseDistressElderlyEmbryoEpigenetic ProcessExploratory/Developmental GrantFibrosisFrequenciesFunctional disorderGoalsHeartHeart DiseasesHeart failureHeterogeneityImmuneImmune responseImmune systemImmunologic SurveillanceImmunologicsImpairmentIndividualInfectionInfiltrationInflammagingInflammationInflammatoryIschemiaKidney DiseasesKnowledgeLeadLeft Ventricular HypertrophyLongevityLung infectionsMalignant NeoplasmsMeasurementMediatingMediator of activation proteinMedicareMissionModelingMolecularMorphologyMusMycobacterium InfectionsMyelogenousMyeloid CellsMyocardial dysfunctionMyocardiumNatural ImmunityOpportunistic InfectionsPathogenesisPathologyPerformancePersonsPharmacologyPhenotypePopulationPredispositionProcessPrognostic FactorProteinsPublic HealthPublishingRNAResearchResolutionResourcesRisk FactorsRoleTechnologyTestingTissuesUnited StatesXCL1 geneadaptive immune responseage relatedagedaging populationbasebeneficiarycardiovascular disorder therapydata integrationdecubitus ulcerfunctional groupheart damageheart functionhigh riskmacrophagemonocytemortality riskmulti-drug resistant pathogenmultiple omicsnon-tuberculosis mycobacterianovel strategiesnovel therapeuticsopportunistic pathogenpathogenpreventprogramsreceptortissue repairtrafficking

项目摘要

项目成果

Murugesan Rajaram的其他基金

相似基金

相关文献

中文摘要
翻译
预计到2050年,美国老年人口将增加三倍,达到8500多万。这个 由于年龄相关的心血管疾病和炎症性疾病,心力衰竭的负担也会增加。为 例如,由于慢性炎症,老年人更容易受到心脏感染,这种炎症被称为“炎症”。 年龄增长。“对这些人的机会性感染通常很容易被清除,但可能会导致严重的 心脏窘迫和死亡。事实上,年龄是非结核性心脏病收缩的主要预后因素。 分枝杆菌(NTM)病,以及相关的心脏播散。显然还有治疗的需要。 可供选择,因为感染非传染性支气管炎的老年人死亡风险高达40%。 先天性和获得性免疫反应在心脏中受到严格调控,以防止适应性不良的炎症, 它可能会在发炎过程中发生故障。最近我们已经证明了一种机会性感染 病原体NTM使老年小鼠易患心律失常(老龄细胞2019)。因为目前没有 对于老年人心脏NTM感染的有效药物治疗,我们相信了解 相关炎症和表型改变的机制可能有助于合理的治疗选择。 我们发现,在老年心脏感染期间,有益的CCR2-,MerTK+心脏常驻巨噬细胞 (CRM)被炎性髓系来源的细胞取代。因此,我们假设炎症会导致 CRM表型中增强的髓系细胞转运、表观遗传重编程和表型转换 组织修复缺陷,这是导致感染相关心脏功能障碍的过程。这样做的目的是 研究计划是:1)确定老年心肌髓系细胞的细胞和表观遗传学特性 感染,以及2)确定增强CRM中MerTK的表达是否提供心脏保护 老老鼠。我们将使用幼鼠(2-3月龄)和老年鼠(18-24月龄)来研究NTM对心脏的影响 功能障碍。多组学(单细胞RNA和ATAC测序)技术的应用将提供 研究心脏内感染和衰老的一般资源。总体而言,我们的使命是定义心脏 巨噬细胞亚群,确定巨噬细胞表型改变的机制及其在感染中的作用 在幼鼠和老年鼠身上。鉴于老龄化中机会性感染造成的巨大且不断增长的公共卫生负担 心脏,以及缺乏基本免疫控制机制的知识,这个项目是理想的 适用于R21机制。此外,确定与衰老相关的巨噬细胞群 功能障碍可能导致治疗老年人心脏功能障碍的新方法和药物。
英文摘要
The United States elderly population is predicted to increase three-fold by 2050, reaching over 85 million. The burden of heart failure will also increase due to age associated cardiovascular and inflammatory diseases. For example, the elderly are more susceptible to cardiac infection due to chronic inflammation, termed “inflamm- aging.” Opportunistic infections of these individuals, which would normally be easily cleared, can result in severe cardiac distress, and death. Indeed, aging is a major prognostic factor for contraction of non-tuberculous mycobacterial (NTM) disease, and associated dissemination to the heart. There is also a clear need for treatment options, as there is up to a 40% risk for death in elderly persons with NTM infection. Innate and adaptive immune responses are tightly regulated in the heart to prevent maladaptive inflammation, which may malfunction during inflammaging. Recently we have demonstrated that infection with an opportunistic pathogen, NTM, predisposes aged mice to cardiac arrhythmia (Ageing Cell 2019). As there are currently no effective pharmacological therapies for cardiac NTM infection within the elderly, we believe understanding the mechanisms involved in associated inflammation and phenotypic changes could assist in rational therapy choice. We have discovered that, during infection of old hearts, beneficial CCR2-, MerTK+ cardiac resident macrophages (CRMs) are replaced with inflammatory myeloid-derived cells. Thus we hypothesize that inflammaging causes enhanced myeloid cell trafficking, epigenetic reprograming and phenotypic switch in CRMs phenotypes, and defective tissue repair, processes that contribute to infection-associated cardiac dysfunction. The goals of this research program are to: 1) Determine cellular and epigenetic identities of aged cardiac myeloid cells during infection, and 2) Determine whether enhancing the expression of MerTK in CRMs provides cardio protection in old mice. We will use young (2-3 months) and old (18-24 months) mice to study the impact of NTM in cardiac dysfunction. Application of multi-omics (Single Cell RNA and ATAC sequencing) technology will provide a general resource for studying infection, and aging, within the heart. Overall, our mission is to define cardiac macrophage subsets, identify the mechanism of macrophage phenotypic changes and its role during infection in young and old mice. Given the large, and growing, public health burden of opportunistic infection within aging hearts, and a lack of knowledge about fundamental immunological control mechanisms, this project is ideally suited for the R21 mechanism. Further, identifying macrophage populations responsible for aging-related dysfunction could lead to new approaches and drugs to treat cardiac dysfunction in elderly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Aging on cardiac macrophage dysfunction and heart failure during infection
  • 批准号:
    10620781
  • 项目类别:
  • 资助金额:
    $19.69万
  • 财政年份:
    2022
  • 负责人:
    Murugesan Rajaram
  • 依托单位:
Molecular mechanism of cardiac inflammation and dysfunction in Pseudomonas aeruginosa infection
  • 批准号:
    10436279
  • 项目类别:
  • 资助金额:
    $44.39万
  • 财政年份:
    2019
  • 负责人:
    Murugesan Rajaram
  • 依托单位:
Mechanisms of Cardioprotection by the Innate Immune System During Influenza Virus Infections
  • 批准号:
    9809007
  • 项目类别:
  • 资助金额:
    $22.72万
  • 财政年份:
    2019
  • 负责人:
    Murugesan Rajaram
  • 依托单位:
Molecular mechanism of cardiac inflammation and dysfunction in Pseudomonas aeruginosa infection
  • 批准号:
    10654794
  • 项目类别:
  • 资助金额:
    $43.13万
  • 财政年份:
    2019
  • 负责人:
    Murugesan Rajaram
  • 依托单位:
海外基金